Sign in

CIK 0001599298

  • Large accelerated filer

Summit Therapeutics Inc.

Sign in to watch
Ticker
SMMT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
371979717
Phone
+1 305-203-2034
Business address
601 BRICKELL KEY DRIVE, SUITE 1000, MIAMI, FL, 33131
Former names
Summit Therapeutics plc, Summit Corp plc
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2024-03-26 Dhingra Ankur Chief Financial Officer Purchase +100,000 $3.75 $375K 354,958
2023-12-13 Dhingra Ankur Chief Financial Officer Purchase +700 $2.15 $2K 235,258
2023-12-13 Dhingra Ankur Chief Financial Officer Purchase +19,700 $2.17 $43K 254,958
2023-03-07 Dhingra Ankur Chief Financial Officer Purchase +196,362 $1.05 $206K 234,558
2022-08-16 Dhingra Ankur Chief Financial Officer Purchase +13,027 $0.97 $13K 39,527
2022-08-16 Dhingra Ankur Chief Financial Officer Purchase +24,658 $0.97 $24K 38,196
2022-08-16 Dhingra Ankur Chief Financial Officer Purchase +11,557 $0.97 $11K 38,057
2022-08-16 Dhingra Ankur Chief Financial Officer Purchase +24,658 $0.97 $24K 38,196
2022-05-31 Dhingra Ankur Chief Financial Officer Grant or award · Stock Option (right to buy) +600,000 600,000

Page 1 of 1 · 9 trades